Divergences in Clinical, Anthropometric, Metabolic, and Hormonal Parameters among Different Phenotypes of Polycystic Ovary Syndrome Presenting at Endocrinology Outpatient Departments: A Multicenter Study from Bangladesh

• Published in: Journal of human reproductive sciences 2020-10, Vol.13 (4), p.277-284
• Main Authors: Kamrul-Hasan, A B M, Aalpona, Fatema Tuz Zahura, Mustari, Marufa, Akter, Farhana, Rahman, Mohammad Motiur, Selim, Shahjada
• Format: Article
• Language: English
• Subjects: Acne; Androgens; Biochemical markers; Body measurements; central obesity; Diabetes mellitus; Dyslipidemia; Endocrinology; Genetic aspects; Genotype & phenotype; Glucose tolerance; Hirsutism; Hypertension; Intolerance; Metabolic disorders; Metabolic syndrome; Metabolism; Original; Ovaries; Phenotype; Phenotypes; Polycystic ovary syndrome; polycystic ovary syndrome phenotypes; Prolactin; Stein-Leventhal syndrome; Testosterone
• ISSN: 0974-1208; 1998-4766
• DOI: 10.4103/jhrs.JHRS_34_20

Polycystic ovary syndrome (PCOS) is a heterogeneous androgen-excess disorder. Data comparing the PCOS phenotypes in Bangladesh are scarce. The objective of this study was to find out the distribution of Rotterdam classified PCOS phenotypes and to compare the phenotypes concerning clinical, anthropometric, metabolic, and hormonal parameters. In this cross-sectional study, 370 PCOS cases in the age group of 20-45 years diagnosed by the Rotterdam consensus criteria were recruited from the endocrinology outpatient departments of several tertiary hospitals of Bangladesh. Metabolic syndrome (MetS) was diagnosed using the International Diabetes Federation criteria. The prevalence of phenotypes A, B, C, and D were 59.2%, 14.1%, 11.9%, and 14.9%, respectively. More than one-third (34.6%) of the women had pre-hypertension (pre-HTN)/hypertension (HTN), 34.1% had abnormal glucose intolerance (AGT), 93.0% had dyslipidemia, and 57.0% had MetS. The hyperandrogenic phenotypes (A, B, and C) had higher prevalence of pre-HTN/HTN, AGT, dyslipidemia, and MetS compared to the normoandrogenic phenotype D, though the differences were statistically insignificant. The clinical and biochemical markers of hyperandrogenism (Ferriman-Gallwey score, hirsutism, acne, and serum testosterone levels) did not differ among the hyperandrogenic phenotypes. The serum prolactin level was highest in phenotype C. No differences were observed in most other clinical, anthropometric, metabolic, and hormonal parameters among the four phenotypes. Phenotype A is the most prevalent phenotype of PCOS in our setting. The prevalence of MetS was considerably high. Most of the clinical, anthropometric, and metabolic parameters were similar across the four PCOS phenotypes in this study.